Skip to main content
. 2021 Mar;9(5):364. doi: 10.21037/atm-20-5136

Figure 2.

Figure 2

Correlation of pathological homologous recombination repair (HRR) gene mutations with residual disease and platinum sensitivity. Data among the three groups were compared with Pearson chi-square tests with P values. (A) Residual disease status among three groups. The R0 rates in the wild-type, germline and somatic homologous recombination repair (HRR) mutated groups were 48.3%, 28.6% and 0%, respectively (P=0.233). (B) Response to platinum treatment in each group. There were no statistically differences among three groups (wild-type vs. germline vs. somatic, 62.1 vs. 42.9 vs. 50%, respectively, P=0.851).